Publications

Selective Alanine Transporter Utilization is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer

Download PDF
Resource: Selective Alanine Transporter Utilization is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer

.

Related Articles

UniFORM: Towards Universal ImmunoFluorescence Normalization for Multiplex Tissue Imaging

Link
Microfluidics-assisted multiplexed biomarker detection for in situ mapping of immune cells in tumor sections

Link